Cleared Traditional

K161513 - Anti-Borrelia burgdorferi US Westernblo...

K161513 is the FDA 510(k) clearance for Anti-Borrelia burgdorferi US Westernblo... by Euroimmun US. It is a Class 2 Microbiology device (product code LSR) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K161513 · Euroimmun US · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2016
Decision
84d
Days
Class 2
Risk

K161513 is an FDA 510(k) clearance for the Anti-Borrelia burgdorferi US Westernblot (IgG). Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by Euroimmun US (Morris Plains, US). The FDA issued a Cleared decision on August 25, 2016 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Euroimmun US devices

Submission Details

510(k) Number K161513 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2016
Decision Date August 25, 2016
Days to Decision 84 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 102d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 51
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K161513.
Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test Kit
K180264 · Gold Standard Diagnostics · May 2018
Sofia Lyme FIA, Sofia 2 analyzer, Sofia 2 Installation Pack
K173691 · Quidel Corporation · Feb 2018
Sofia Lyme FIA, Sofia Lyme Control Set
K163713 · Quidel Corporation · Oct 2017
ZEUS ELISA BORRELIA VLSE-1/PEPC10 IGG/IGM TEST SYSTEM
K113397 · Zeus Scientific, Inc. · Jul 2012
ATHENA MULTI-LYTE BORRELIA VLSE-1/PEPC10 PLUS TEST SYSTEM
K100728 · Zeus Scientific, Inc. · Jul 2010
PLATELIA LYME IGM
K081362 · Bio-Rad · Jun 2008